8.15

3.95% 0.31

Profound Medical Corp (PROF)

Overview News Price History Option Chain Discussions Forecast Stock Split

Profound Medical Corp stock is traded at $8.15, with a volume of 13,506. It is up +3.95% in the last 24 hours and up +11.49% over the past month. Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

Previous Close:

$7.84

Open:

$7.86

24h Volume:

13,506

Relative Volume:

0.28

Market Cap:

$193.59M

Revenue:

$8.98M

Net Income/Loss:

$-31.39M

P/E Ratio:

-5.9489

EPS:

-1.37

Net Cash Flow:

$-24.83M

1W Performance:

+5.98%

1M Performance:

+11.49%

6M Performance:

+11.49%

1Y Performance:

-25.57%

1-Day Range:

$7.825

$8.17

1-Week Range:

$7.4101

$8.17

52-Week Range:

$7.11

$11.42

Profound Medical Corp Stock (PROF) Company Profile

Name

Profound Medical Corp

Sector

Healthcare (1200)

Industry

Medical Devices (153)

Phone

Address

Employee

131

Twitter

@profoundmedical

Next Earnings Date

2024-11-07

Latest SEC Filings

PROF's Discussions on Twitter

Compare PROF with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PROF Profound Medical Corp	8.15	193.59M	8.98M	-31.39M	-24.83M	-1.37
ABT Abbott Laboratories	118.95	208.18B	41.22B	5.77B	6.49B	2.94
SYK Stryker Corp	388.14	148.70B	21.97B	3.59B	3.21B	6.74
BSX Boston Scientific Corp	90.75	133.32B	15.91B	1.79B	1.89B	0.82
MDT Medtronic Plc	86.27	111.27B	33.00B	4.29B	5.50B	2.71
EW Edwards Lifesciences Corp	72.07	42.66B	6.60B	4.16B	490.10M	2.34

Profound Medical Corp Stock (PROF) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-23-24	Initiated	Lake Street	Buy
Jul-16-24	Upgrade	Stifel	Hold → Buy
Nov-28-23	Initiated	Stifel	Hold
Aug-04-23	Downgrade	Raymond James	Strong Buy → Outperform
Mar-21-23	Downgrade	Jefferies	Buy → Hold
Sep-15-20	Initiated	Jefferies	Buy

View All

Profound Medical Corp Stock (PROF) Latest News

Nov 26, 2024

Profound Medical to Unveil Next TULSA-AI® Module, 'UA Alignment Assistant' - The Manila Times

Nov 26, 2024

Nov 25, 2024

(PROF) On The My Stocks Page - Stock Traders Daily

Nov 25, 2024

Nov 15, 2024

GAGNON SECURITIES LLC Acquires Shares in Profound Medical Corp - GuruFocus.com

Nov 15, 2024

Nov 14, 2024

Profound Medical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 14, 2024

Nov 13, 2024

Medeloop Secures $15.5 Million in Series A Funding to Accelerate Medical Research - GlobeNewswire

Nov 13, 2024

Nov 12, 2024

Profound Medical to Participate in the Stifel 2024 Healthcare Conference - The Manila Times

Nov 12, 2024

Fact check: Are late-term abortions ever ‘medically necessary’? - Al Jazeera English

Nov 12, 2024

Nov 11, 2024

Profound Medical Corp. (NASDAQ:PROF) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 11, 2024

What is Raymond James' Forecast for TSE:PRN FY2028 Earnings? - MarketBeat

Nov 11, 2024

FY2028 Earnings Forecast for PROF Issued By Raymond James - MarketBeat

Nov 11, 2024

Nov 09, 2024

Profound Medical Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance

Nov 09, 2024

Nov 08, 2024